| Passed by the House February 14, 2014 Yeas 85 FRANK CHOPP ________________________________________ Speaker of the House of Representatives Passed by the Senate March 6, 2014 Yeas 49 BRAD OWEN ________________________________________ President of the Senate | I, Barbara Baker, Chief Clerk of the House of Representatives of the State of Washington, do hereby certify that the attached is SUBSTITUTE HOUSE BILL 2153 as passed by the House of Representatives and the Senate on the dates hereon set forth. BARBARA BAKER ________________________________________ Chief Clerk | |
| Approved March 28, 2014, 2:21 p.m. JAY INSLEE ________________________________________ Governor of the State of Washington | March 31, 2014 Secretary of State State of Washington |
| State of Washington | 63rd Legislature | 2014 Regular Session |
READ FIRST TIME 01/28/14.
AN ACT Relating to the treatment of eosinophilic gastrointestinal associated disorders; adding a new section to chapter 41.05 RCW; and adding a new section to chapter 48.43 RCW.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1 A new section is added to chapter 41.05 RCW
to read as follows:
(1) Each health benefit plan offered to public employees and their
covered dependents under this chapter that is not subject to chapter
48.43 RCW and that is issued or renewed after December 31, 2015, must
offer benefits or coverage for medically necessary elemental formula,
regardless of delivery method, when a licensed physician or other
health care provider with prescriptive authority:
(a) Diagnoses a patient with an eosinophilic gastrointestinal
associated disorder; and
(b) Orders and supervises the use of the elemental formula.
(2) Nothing in this section prohibits a health benefit plan from
requiring prior authorization or imposing other appropriate utilization
controls in approving coverage for medically necessary elemental
formula.
NEW SECTION. Sec. 2 A new section is added to chapter
48.43 RCW
to read as follows:
(1) Each health benefit plan issued or renewed after December 31,
2015, must offer benefits or coverage for medically necessary elemental
formula, regardless of delivery method, when a licensed physician or
other health care provider with prescriptive authority:
(a) Diagnoses a patient with an eosinophilic gastrointestinal
associated disorder; and
(b) Orders and supervises the use of the elemental formula.
(2) Nothing in this section prohibits a health benefit plan from
requiring prior authorization or imposing other appropriate utilization
controls in approving coverage for medically necessary elemental
formula.